Analytical Data
-
Gene name
CCNH
- Application
-
Alternative Names
CCNH;Cyclin-H
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P51946
-
Expression Region
1-323aa
-
AA Sequence
MYHNSSQKRH WTFSSEEQLA RLRADANRKF RCKAVANGKV LPNDPVFLEP HEEMTLCKYY EKRLLEFCSV FKPAMPRSVV GTACMYFKRF YLNNSVMEYH PRIIMLTCAF LACKVDEFNV SSPQFVGNLR ESPLGQEKAL EQILEYELLL IQQLNFHLIV HNPYRPFEGF LIDLKTRYPI LENPEILRKT ADDFLNRIAL TDAYLLYTPS QIALTAILSS ASRAGITMES YLSESLMLKE NRTCLSQLLD IMKSMRNLVK KYEPPRSEEV AVLKQKLERC HSAELALNVI TKKRKGYEDD DYVSKKSKHE EEEWTDDDLV ESL
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCNH (cell cycle and apoptosis regulatory protein) is a crucial protein that plays a significant role in regulating both the cell cycle and apoptosis, illustrating its importance in cellular processes and potential implications in cancer research. As a member of the cyclin family, CCNH is involved in various cellular mechanisms, including transcription regulation and interaction with cyclin-dependent kinases (CDKs), which are essential for the progression of the cell cycle. The dysfunction or aberrant expression of CCNH has been linked to several malignancies, making it a target for therapeutic interventions. Researchers have focused on the recombinant expression of CCNH to study its structure-function relationships, enhance our understanding of its role in cell cycle regulation, and explore its potential as a biomarker or therapeutic target in oncology. By producing recombinant CCNH, scientists aim to unlock insights into its interactions with other cellular proteins and components, and its contribution to disease mechanisms, thereby providing a foundation for the development of novel cancer treatments.
